We are delighted to announce that Professor Marian Knight, NPEU researcher and Professor of Maternal and Child Population Health, has been awarded a Fellowship ad eundem by the Royal College of Obstetricians and Gynaecologists (RCOG).
Fellowship ad eundem is the highest honour that RCOG can bestow on people who are not members of the College in recognition of their contribution to the advancement of the science and practice of obstetrics and gynaecology.
We congratulate Marian on her outstanding achievement!
The ELFIN trial, which will evaluate whether giving very preterm infants supplemental lactoferrin (a natural antibiotic protein from cow's milk) reduces the number of serious infections has reached its recruitment target of 2,200 participants.
The 2,200th baby was recruited at the Royal Victoria Infirmary, Newcastle.
Responding to this news, ELFIN Chief Investigator, Professor Bill McGuire stated
Congratulations and very many thanks to the whole ELFIN team; Paula, Monika and James at the co-ordinating centre in the NPEU trials unit; the site investigators and research nurses across more than 100 neonatal units from Kent to Kirkcaldy, Preston to Portsmouth, Sunderland to Swansea, and Belfast to Bradford; and the thousands of altruistic families across the country who trusted us to care for their babies at a time of great stress by allowing them to participate in this trial. We aim now to complete the task of collating and analysing all of the trial data, and look forward to sharing the findings in 2018.
ELFIN is funded by the National Institute for Health Research’s Health Technology Assessment Programme. University of Oxford is the research sponsor.
The NPEU Clinical Trials Unit (CTU) has been awarded full CTU registration by the UK Clinical Research Collaboration (UKCRC). The Review Committee noted that the application submitted for the 2017 registration call “provided clear evidence of operational experience in the design and delivery of large scale multicentre clinical trials.” The committee concluded “a strong application had been presented from a very good free standing unit which met the criteria for Full Registration”. Our congratulations go out to the entire NPEU CTU team.
Maggie will be delivering the SRIP Lecturer Award titled, 'Starting with the baby: psychological aspects of pregnancy, birth and development'.
Reem will be discussing the challenges and complexities of women with learning disabilities in maternity services research and Jane will be sharing findings from a national survey regarding the care and outcome of care experienced by women with mental health problems in pregnancy.
Poster flash presentations 'Father involvement in early child upbringing and mental health outcomes in the pre-adolescent years' by Charles and 'Maternity care experiences of mothers with multiple disadvantages in England: a qualitative descriptive study' by Jenny will be on display throughout the conference.
If you are attending the conference, please say hello.
The number of disabled women choosing to become mothers is growing. However, stigma still exists about such women’s capabilities. Healthcare professionals may be concerned that these women will not be able to cope with pregnancy and motherhood.
The findings indicate some gaps in maternity care provision for these women relating to interpersonal aspects of care: communication, feeling listened to and supported, involvement in decision making, having a trusted and respected relationship with clinical staff. Women from all disability groups wanted more postnatal contacts and help with infant feeding.
Poppi investigators Dr Rebeccah Slater and Dr Fiona Moultrie recently featured in a BBC Radio 4 programme entitled ‘From Agony to Analgesia’. The episode, ‘Seeing Pain’, was broadcast on 16th August 2017 and explored current research in the field of pain, including areas such as pain measurement in premature babies, phantom limb syndrome and chronic pain. Dr Slater and Dr Moultrie explain current approaches used to measure pain in babies, and the possibility of using brain activity as a new measure of pain. In particular, they discuss how pain could be determined specifically in premature babies in the context of the Poppi trial. The full radio programme can be accessed at http://www.bbc.co.uk/programmes/b08r1tsx#play.
New research has identified 10 core outcomes that key stakeholders consider most important in determining whether treatment of children with Hirschsprung’s disease (HD) has been successful. This research, titled the NETS¹ᴴᴰ study, has been published in the Archives of Disease in Childhood, and was conducted by NPEU researchers Ben Allin, Marian Knight and Jenny Kurinczuk and consultant paediatric surgeons Gregor Walker, Tim Bradnock and Simon Kenny. The study team worked with around 150 stakeholders including people with HD, parents of children with HD and healthcare professionals managing children with HD. Together they developed a HD core outcome set (COS) of 10 outcomes, which includes measures for mortality, quality of life, bowel function and unplanned reoperation.
HD is a rare disorder present at birth in which the nerves within the bowel are not properly developed. Whilst there are many ways to treat HD, no gold standard management strategy has been identified. Use of this HD COS can reduce the variability of reported outcomes of HD, making it easier to identify gold standard treatments for children with HD. You can read the published research in full here. Further research on the impact of different surgical interventions on the HD COS will begin in September 2017.